BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21350687)

  • 1. Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis.
    Roh HS; Lee SY; Yoon JS
    Korean J Ophthalmol; 2011 Feb; 25(1):1-7. PubMed ID: 21350687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular aspects of myasthenia gravis.
    Barton JJ; Fouladvand M
    Semin Neurol; 2000; 20(1):7-20. PubMed ID: 10874773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of Ocular Myasthenia Gravis: Retrospective Multicenter Analysis.
    Nagia L; Lemos J; Abusamra K; Cornblath WT; Eggenberger ER
    Ophthalmology; 2015 Jul; 122(7):1517-21. PubMed ID: 25892018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis and associated autoimmune diseases in children.
    Tsao CY; Mendell JR; Lo WD; Luquette M; Rennebohm R
    J Child Neurol; 2000 Nov; 15(11):767-9. PubMed ID: 11108515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diplopia in a patient presenting with "blurred vision": a case report.
    Harrison A; Mudhar O; Yoo J; Rampal M
    J Med Case Rep; 2023 Sep; 17(1):402. PubMed ID: 37679826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors for the prognosis of myasthenia gravis.
    Wang L; Zhang Y; He M
    BMC Neurol; 2017 Apr; 17(1):77. PubMed ID: 28420327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular myasthenia: diagnosis and treatment].
    Stojkovic T; BĂ©hin A
    Rev Neurol (Paris); 2010 Dec; 166(12):987-97. PubMed ID: 21075410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
    J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the frontline: what an optometrist needs to know about myasthenia gravis.
    Pruitt JA; Ilsen PF
    Optometry; 2010 Sep; 81(9):454-60. PubMed ID: 20655284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis with ocular involvement in older patients.
    Weizer JS; Lee AG; Coats DK
    Can J Ophthalmol; 2001 Feb; 36(1):26-33. PubMed ID: 11227387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical and surgical treatment for ocular myasthenia.
    Benatar M; Kaminski H
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis.
    Akan O; Baysal-Kirac L
    Acta Neurol Belg; 2021 Oct; 121(5):1131-1140. PubMed ID: 33439450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of corticosteroids on ocular myasthenia gravis.
    Kupersmith MJ; Moster M; Bhuiyan S; Warren F; Weinberg H
    Arch Neurol; 1996 Aug; 53(8):802-4. PubMed ID: 8759987
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.